EPIAXIS THERAPEUTICS PTY LTD has a total of 29 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2014. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS, THE CORP OF THE TRUSTEES OF THE ORDER OF THE SISTERS OF MERCY IN QUEENSLAND and US GOV SEC HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 4 | |
#4 | Singapore | 4 | |
#5 | United States | 3 | |
#6 | Japan | 2 | |
#7 | China | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Enzymes | |
#6 | Measuring microorganism processes | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rao Sudha | 27 |
#2 | Milburn Peter | 7 |
#3 | Zafar Anjum | 4 |
#4 | Sudha Rao | 2 |
#5 | Anjum Zafar | 2 |
#6 | Mccuaig Robert | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020172712A1 | Methods and agents for assessing t-cell function and predicting response to therapy | |
CN111587120A | Immunogenic compositions and uses thereof | |
AU2017214761A1 | Proteinaceous compounds and uses therefor |